Document Detail


The reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control.
MedLine Citation:
PMID:  21519726     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Introduction: The high prevalence of metabolic syndrome (MS) in Spain requires additional efforts for prevention and treatment. Objective: The study RESMENA-S aims to improve clinical criteria and biomarkers associated with MS though an integral therapy approach. Methods: The study is a randomized prospective parallel design in which is expected to participate a total of 100 individuals. The RESMENA-S group (n = 50) is a personalized weight loss (30% energy restriction) diet, with a macronutrient distribution (carbohydrate / fat / protein) of 40/30/30, high meal frequency (7 / day), low glycemic index/load and high antioxidant capacity as well as a high adherence to the Mediterranean diet. The control group (n = 50) is assigned to a diet with the same energy restriction and based on the American Heart Association pattern. Both experimental groups are under dietary and psychological control during 8 weeks. Likewise, for an additional period of 16 weeks of self-control, is expected that volunteers will follow the same pattern but with no dietary advice. Results: Anthropometrical data and body composition determinations as well as blood and urine samples are being collected at the beginning and end of each phase. This project is registered at www.clinicaltrials.gov with the number NCT01087086 and count with the Research Ethics Committee of the University of Navarra approval (065/2009). Conclusions: Intervention trials to promote the adoption of dietary patterns and healthy lifestyle are of great importance to identify the outcomes and nutritional mechanisms that might explain the link between obesity, metabolic syndrome and associated complications.
Authors:
M A Zulet; I Bondia-Pons; I Abete; R de la Iglesia; P López-Legarrea; L Forga; S Navas-Carretero; J A Martínez
Related Documents :
8033496 - Effect of the acyl-coa:cholesterol acyltransferase inhibitor dup 128 on cholesterol abs...
1390586 - Beta-vldl-induced cholesterol ester deposition in macrophages may be regulated by neutr...
8543556 - Role of acyl coenzyme a cholesterol acyltransferase in intrahepatic processing of apo b...
3620486 - Cholesterol is necessary for triacylglycerol-phospholipid emulsions to mimic the metabo...
15610486 - Influence of d-lactate on metabolic acidosis and on prognosis in neonatal calves with d...
8033496 - Effect of the acyl-coa:cholesterol acyltransferase inhibitor dup 128 on cholesterol abs...
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Nutricion hospitalaria : organo oficial de la Sociedad Espanola de Nutricion Parenteral y Enteral     Volume:  26     ISSN:  1699-5198     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-4-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9100365     Medline TA:  Nutr Hosp     Country:  -    
Other Details:
Languages:  ENG     Pagination:  16-26     Citation Subset:  -    
Affiliation:
Department of Nutrition, Food Sciences, Physiology & Toxicology, University of Navarra, Pamplona, Spain.
Vernacular Title:
El estudio RESMENA-S: reducción del síndrome metabólico; una estrategia multidisciplinar basada en la crononutrición y la educación nutricional, junto con control dietético y psicológico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Consensus on paediatric enteral nutrition access: a document approved by SENPE/SEGHNP/ANECIPN/SECP.
Next Document:  Importance of water in the hydration of the Spanish population: FESNAD 2010 document.